CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Open-market sale Chief Executive Officer sold 60 shares at $7.50 ($450)
- ARS Other Annual Report to Security Holders
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- 4 Open-market sale Director sold 1,400 shares at $8.00 ($11,200)
- 8-K Event Executive or director change
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 4 Open-market sale Chief Executive Officer sold 11,960 shares at an average $8.06 ($96,400)
- 4 Open-market sale Chief Executive Officer sold 6,340 shares at $8.06 ($51,100)
- 4 Open-market sale Chief Executive Officer sold 8,200 shares at $8.06 ($66,092)
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- 4 Open-market sale Chief Executive Officer sold 480 shares at $7.50 ($3,600)
Page 64 of 74 · 1,465 filings